Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0AD1L
|
||||
| Former ID |
DIB020739
|
||||
| Drug Name |
PMBA
|
||||
| Synonyms |
3-[2'-phosphonomethyl[1,1'-biphenyl]-3-yl]alanine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [467627] | ||
| Formula |
C16H18NO5P
|
||||
| InChI |
InChI=1S/C16H18NO5P/c17-15(16(18)19)9-11-4-3-6-12(8-11)14-7-2-1-5-13(14)10-23(20,21)22/h1-8,15H,9-10,17H2,(H,18,19)(H2,20,21,22)
|
||||
| InChIKey |
NCEGJIHRQBRVJQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Glycine receptor | Target Info | Antagonist | [543823] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Reactome | Ligand-gated ion channel transport | ||||
| WikiPathways | Iron uptake and transport | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.